Publication of Data Shows High Fusion Rate in Patients Treated with PEMF Therapy Using the Orthofix SpinalStim DeviceBusiness Wire • 07/12/21
Orthofix Announces U.S. Launch and First Patient Implant of 3D-Printed FORZA Titanium PLIF Spacer System with Nanovate TechnologyBusiness Wire • 06/29/21
Orthofix Announces Participation in Upcoming JMP Securities Life Sciences ConferenceBusiness Wire • 06/11/21
Orthofix Announces Participation in Upcoming Jefferies Virtual Healthcare ConferenceBusiness Wire • 05/27/21
Orthofix Announces US and European Full Market Launch of OSCAR PRO System for Removal of Cement During Complex Joint Revision SurgeriesBusiness Wire • 05/17/21
Orthofix M6-C Artificial Cervical Disc IDE Study Three- and Four-Year Data to be Presented at ISASSBusiness Wire • 05/13/21
Orthofix Announces FDA Clearance of the OrthoNext Digital Platform for the JuniOrtho Plating SystemBusiness Wire • 05/10/21
Orthofix Medical's (OFIX) CEO Jon Serbousek on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 04/30/21
Orthofix Announces Exclusive US License for IGEA's Bone and Joint Stimulation DevicesBusiness Wire • 04/28/21
Orthofix Schedules First Quarter Earnings Release and Conference Call for April 30, 2021Business Wire • 04/22/21
Orthofix Announces FDA Clearance and First Patient Implant of the 3D-Printed FORZA Titanium TLIF Spacer System with Nanovate TechnologyBusiness Wire • 04/22/21
Orthofix Announces FDA Clearance and Initial Patient Implant of the Company's First 3D-Printed Titanium Cervical Spacer System with Nanovate TechnologyBusiness Wire • 04/05/21
Orthofix Medical Inc. (OFIX) CEO Jon Serbousek on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/26/21